Antithrombotic drugs and risk of hemorrhagic stroke in the general population

Neurology

Volumn 82, Issue 13, 2014, Pages 1193-

  Vidale, Simone ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; RIVAROXABAN; WARFARIN;

AGE DISTRIBUTION; ANEURYSM; ANTICOAGULATION; BRAIN HEMORRHAGE; CLINICAL ASSESSMENT TOOL; DEMOGRAPHY; DISEASE PREDISPOSITION; EDITORIAL; HAS BLED SCORING SYSTEM; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; POPULATION SURVEILLANCE; STROKE;

EID: 84898718377     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000445976.98849.b1     Document Type: Editorial

References (4)

1. Garcia-Rodriguez LA, Gaist D, Morton J, et al. Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology 2013;81:566-574.
2. Hasan DM, Mahaney KB, Brown RD Jr, et al. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 2011;42:3156-3162.
3. Mahaffey KW, Wojdyla D, Hankey G, et al. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial. Ann Intern Med 2013;158:861-868.
4. Field TS, Nakajima M, Benavente OR. Combination aspirin and clopidogrel for secondary prevention of ischemic stroke. Curr Treat Opt Cardiovasc Med 2013;15:348-359.